CytomX Therapeutics, Inc. (CTMX)
After hours:
| Previous close | 1.4200 |
| Open | 1.4500 |
| Bid | 1.4800 x 400 |
| Ask | 1.5100 x 600 |
| Day's range | 1.4305 - 1.5100 |
| 52-week range | 1.0400 - 5.8500 |
| Volume | |
| Avg. volume | 7,021,072 |
| Market cap | 116.879M |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | 7.14 |
| EPS (TTM) | 0.2100 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.32 |
Insider MonkeyCytomX Therapeutics, Inc. (CTMX): The Best One-Dollar Stock to Buy Now?
We recently compiled a list of the 10 Best One-Dollar Stocks To Buy Now. In this article, we are going to take a look at where CytomX Therapeutics, Inc. (NASDAQ:CTMX) stands against the other one-dollar stocks. The upward trend in the stock market has resumed, supported by strong first-quarter and second-quarter results that have relieved […]
Simply Wall St.CytomX Therapeutics, Inc. (NASDAQ:CTMX) is definitely on the radar of institutional investors who own 47% of the company
Key Insights Institutions' substantial holdings in CytomX Therapeutics implies that they have significant influence...
GlobeNewswireCytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a fireside chat at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference on Tuesday, June 25, 2024, at 2:00 p.m. ET. A live webcast of the presentation will be available on the Events and Presenta
